Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | CA1 | P00915 | 4/20 | 0.60 |
| ▸ | CA2 | P00918 | 4/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24855685 | 0.88 | TP53 (0.55) | TP53KDM4EALDH1A1LMNACYP3A4 | |
| SCHEMBL3790244 | 0.83 | CA1 (0.58) | TP53KDM4EALDH1A1LMNACYP3A4 | |
| SCHEMBL9454007 | 0.81 | TSHR (0.54) | TP53KDM4EALDH1A1LMNACYP3A4 | |
| Methoxymethane SCHEMBL10659099 | 0.80 | TSHR (0.59) | TP53KDM4EALDH1A1LMNACYP3A4 | |
| SCHEMBL26611717 | 0.79 | ALDH1A1 (0.48) | TP53KDM4EALDH1A1LMNACYP3A4 | |
| SCHEMBL11151784 | 0.79 | MAPK1 (0.48) | TP53KDM4EALDH1A1LMNACYP3A4 | |
| SCHEMBL691908 | 0.79 | TSHR (0.52) | TP53KDM4EALDH1A1LMNACYP3A4 | |
| 3-Methoxycatechol SCHEMBL29477155 | 0.78 | TP53 (1.00) | TP53KDM4EALDH1A1LMNACYP3A4 | |
| 3-Methoxycatechol SCHEMBL67332 | 0.78 | TP53 (1.00) | TP53KDM4EALDH1A1LMNACYP3A4 | |
| SCHEMBL4634640 | 0.78 | GRM5 (0.49) | TP53KDM4EALDH1A1LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0299890-B1 | PROCESS FOR THE CHLORINATION OF PHENOLIC COMPOUNDS | RHONE-POULENC CHIMIE (FR) | 1991-12-11 | — | — | EP | claimed |
| EP-0283411-B1 | PROCESS FOR CHLORINATING PHENOLIC COMPOUNDS | RHONE-POULENC CHIMIE (FR) | 1991-08-07 | — | — | EP | claimed |
| EP-0255452-B1 | PROCESS FOR CHLORINATING PHENOLIC COMPOUNDS | RHONE-POULENC CHIMIE (FR) | 1990-01-24 | — | — | EP | claimed |
| EP-0299890-A1 | Process for the chlorination of phenolic compounds | RHONE-POULENC CHIMIE (FR) | 1989-01-18 | — | — | EP | claimed |
| EP-0283411-A1 | Process for chlorinating phenolic compounds | RHONE-POULENC CHIMIE (FR) | 1988-09-21 | — | — | EP | claimed |
| EP-0255452-A1 | Process for chlorinating phenolic compounds | RHONE-POULENC CHIMIE (FR) | 1988-02-03 | — | — | EP | claimed |
| EP-0211775-A1 | Process for nitrating phenolic compounds | RHONE-POULENC CHIMIE (FR) | 1987-02-25 | — | — | EP | claimed |
| US-20260092052-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2026-04-02 | — | — | US | disclosed |
| WO-2025026457-A1 | MODIFIED FLAVONE COMPOUNDS AND USE THEREOF | 苏州格兰科医药科技有限公司 | 2025-02-06 | — | — | WO | disclosed |
| CN-119306735-A | Organic compound, application thereof and organic electroluminescent device | 北京鼎材科技有限公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-119118983-A | Xanthone compound and intermediate thereof, preparation method, pharmaceutical composition and application | 上海药坦药物研究开发有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-113493442-B | Pyrrolidone derivative as glucokinase activator and preparation method and application thereof | 天津药物研究院有限公司 | 2024-11-08 | — | — | CN | disclosed |
| US-20240109874-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2024-04-04 | — | — | US | disclosed |
| EP-0055197-A1 | Process for the synthesis of metachlorophenols | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1982-06-30 | — | — | EP | disclosed |
| EP-0055196-A1 | Process for the synthesis of metachlorophenols | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1982-06-30 | — | — | EP | disclosed |
| EP-0055198-A1 | Process for the synthesis of metachlorophenols | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1982-06-30 | — | — | EP | disclosed |
| EP-0050326-A2 | Benzo(b)thiophenes | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1982-04-28 | — | — | EP | disclosed |
| EP-0003295-B1 | PHENOXY-PHENOXY-ALKYLCARBOXYLIC ACID DERIVATIVES WITH HERBICIDAL ACTIVITY, THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USE | CIBA-GEIGY AG (CH) | 1981-11-25 | — | — | EP | disclosed |
| EP-0003295-A1 | Phenoxy-phenoxy-alkylcarboxylic acid derivatives with herbicidal activity, their preparation, compositions containing them and their use | CIBA-GEIGY AG (CH) | 1979-08-08 | — | — | EP | disclosed |
| US-3959388-A | Preparation of phloroglucinol or its monomethyl ether | ANDENO B.V. (NL) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109874-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | CHRM1, CHRM5, CHRM2 | TP53 2500/4885KDM4E 1279/4885ALDH1A1 2868/4885 |
| US-20260092052-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | CHRM1, CHRM2, CHRM4 | TP53 4212/4885KDM4E 1132/4885ALDH1A1 2698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.